# ClinicalTrials.gov record NCT06662539

> PeptideScanner retained ClinicalTrials.gov record NCT06662539 at 2026-07-30T16:22:22.334Z. Its registry update date was 2026-03-23, and PeptideScanner's reviewed identity mapping was petrelintide.

- Evidence object: `story:clinicaltrials-gov-nct06662539-petrelintide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-03-23
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06662539-petrelintide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06662539-petrelintide-v1.json
- Content SHA-256: `f91b994b9d6e54fe6f3c7eda7e79ff54de75a426d231fe660191ff07d1093389`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT06662539 ([`ctg-observation-nct06662539-2026-03-23-25a9d8533efb`](#source-ctg-observation-nct06662539-2026-03-23-25a9d8533efb))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06662539 at 2026-07-30T16:22:22.334Z. Its registry update date was 2026-03-23, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct06662539-2026-03-23-25a9d8533efb`](#source-ctg-observation-nct06662539-2026-03-23-25a9d8533efb))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06662539 at 2026-07-30T16:22:22.334Z. Its registry update date was 2026-03-23, and PeptideScanner's reviewed identity mapping was petrelintide. ([`ctg-observation-nct06662539-2026-03-23-25a9d8533efb`](#source-ctg-observation-nct06662539-2026-03-23-25a9d8533efb))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06662539-2026-03-23-25a9d8533efb`](#source-ctg-observation-nct06662539-2026-03-23-25a9d8533efb))

## Sources

<a id="source-ctg-observation-nct06662539-2026-03-23-25a9d8533efb"></a>
- **ClinicalTrials.gov record NCT06662539 · retained source version 2026-03-23:25a9d8533efb66766440e5abf5b03342f70235dae33ae71a773e757bb8847402** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06662539) (`ctg-observation-nct06662539-2026-03-23-25a9d8533efb`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06662539." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06662539-petrelintide-v1.json SHA-256: f91b994b9d6e54fe6f3c7eda7e79ff54de75a426d231fe660191ff07d1093389.